Free  Retracted articles continue to do harm

Marketing Authorisations

Fezolinetant (Veoza°) for menopause-related hot flushes

Dupilumab (Dupixent°) in eosinophilic oesophagitis

Momelotinib (Omjjara°) in myelofibrosis

Rucaparib (Rubraca°) in "advanced" ovarian cancer, as "maintenance" treatment after first-line chemotherapy

Letermovir (Prevymis°) in the prevention of CMV infection following kidney transplantation

MRNA RSVPreF vaccine (mResvia°) in the prevention of RSV infections from 60 years of age

RSVPreF3/AS01E vaccine (Arexvy°) from 50 years of age

Ivacaftor + tezacaftor + elexacaftor (Kaftrio°) sachets in cystic fibrosis from 2 years of age

Pembrolizumab (Keytruda°) after surgery in certain renal cancers

Dolutegravir + abacavir + lamivudine (Triumeq°) in HIV infection in children weighing 6 kg to 14 kg

Risperidone oral solution in children: overdoses caused by unsuitable oral syringes

Type 2 diabetes and metformin

Pre-exposure prophylaxis for HIV (PrEP) in women

Adverse Effects

Adverse effects of nirsevimab: limited data after one season of use in infants

Inset. RSVPreF vaccine in pregnant women: significant risks

Co-administration of an mRNA covid-19 vaccine and an influenza vaccine: no notable safety signal

Cabergoline: fibrotic disorders and heart valve disease

RSV vaccines: Guillain-Barré syndrome

Paracetamol in patients aged 65 years or older: adverse effects similar to those of NSAIDs

Triptans and breastfeeding: breast pain and problems with milk ejection

Common stem: -triptan

Outlook

Methylphenidate: the youngest children in a given school year at higher risk of starting treatment

Payments to health sector actors: Sanofi tops the list of pharmaceutical companies in France

Masthead

Free  Masthead